Evidence map›Paper›PMID 27073088›Full record

ArticlemBio2016

Cytosolic Replication of Group A Streptococcus in Human Macrophages.

Alan M O'Neill, Teresa L M Thurston, David W Holden

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in mBio, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 53 papers.

0numbers the graph read from it
0cells of the map it votes in
53citing papers in PubMed
9.7field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

53 citing papers in PubMed, 77 citations in OpenAlex.

  1. Review
  2. Comparing virulence profile of dominantInfectious diseases & immunity · 2026
    Article
  3. Lysosomal permeabilization by Group AInfection and immunity · 2026
    Article
  4. Article
  5. Review
  6. Review
  7. Lysosomal permeabilization by Group AbioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Review
  10. Review
  11. Clinical microbiology reviews · 2024
    Review
  12. Article
  13. Group AInfection and immunity · 2024
    Article
  14. Interplay between group AMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  15. Expanding the genetic toolbox for the obligate human pathogenFrontiers in bioengineering and biotechnology · 2024
    Article
  16. Article
  17. Article
  18. Role of serotype and virulence determinants ofFrontiers in cellular and infection microbiology · 2023
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Alan M O'NeillMRC Centre for Molecular Bacteriology and Infection, Imperial College London, United Kingdom.
Teresa L M ThurstonMRC Centre for Molecular Bacteriology and Infection, Imperial College London, United Kingdom.
David W HoldenMRC Centre for Molecular Bacteriology and Infection, Imperial College London, United Kingdom d.holden@imperial.ac.uk.
Imperial College London · GB

Funding

Medical Research Council MR/K027077/1Wellcome Trust
6 · The paper itself

Abstract

unlabelledAs key components of innate immune defense, macrophages are essential in controlling bacterial pathogens, including group A Streptococcus(GAS). Despite this, only a limited number of studies have analyzed the recovery of GAS from within human neutrophils and macrophages. Here, we determined the intracellular fate of GAS in human macrophages by using several quantitative approaches. In both U937 and primary human macrophages, the appearance over time of long GAS chains revealed that despite GAS-mediated cytotoxicity, replication occurred in viable, propidium iodide-negative macrophages. Whereas the major virulence factor M1 did not contribute to bacterial growth, a GAS mutant strain deficient in streptolysin O (SLO) was impaired for intracellular replication. SLO promoted bacterial escape from the GAS-containing vacuole (GCV) into the macrophage cytosol. Up to half of the cytosolic GAS colocalized with ubiquitin and p62, suggesting that the bacteria were targeted by the autophagy machinery. Despite this, live imaging of U937 macrophages revealed proficient replication of GAS after GCV rupture, indicating that escape from the GCV is important for growth of GAS in macrophages. Our results reveal that GAS can replicate within viable human macrophages, with SLO promoting GCV escape and cytosolic growth, despite the recruitment of autophagy receptors to bacteria. IMPORTANCE: Classically regarded as an extracellular pathogen, GAS can persist within human epithelial cells, as well as neutrophils and macrophages. Some studies suggest that GAS can modulate its intracellular vacuole to promote survival and perhaps replicate in macrophages. However, an in-depth single-cell analysis of the dynamics of survival and replication is lacking. We used macrophage-like cell lines and primary macrophages to measure the intracellular growth of GAS at both the population and single-cell levels. While CFU counts revealed no increase in overall bacterial growth, quantitative fluorescence microscopy, flow cytometry, and time-lapse imaging revealed bacterial replication in a proportion of infected macrophages. This study emphasizes the importance of single-cell analysis especially when studying the intracellular fate of a pathogen that is cytotoxic and displays heterogeneity in terms of intracellular killing and growth. To our knowledge, this study provides the first direct visualization of GAS replication inside human cells.

Indexed as

Bacterial ProteinsCytosolHumansMacrophagesMicrobial ViabilityStreptococcal InfectionsStreptococcus pyogenesStreptolysinsU937 CellsVirulence FactorsBacterial Proteinsstreptolysin OStreptolysinsVirulence Factors

Identifiers

PMID27073088
PMCPMC4959517
OpenAlexW2337397338

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.